Mission accomplished: NASA doctor receives personalized leukemia treatment

Conquest Spring 2018
MD Anderson’s chair of Genetics, Guillermina “Gigi” Lozano, Ph.D., is a trailblazer in our understanding of the p53 gene’s role in cancer development. Lozano was the first to establish p53 as a transcriptional activator of other genes. Transcription is the first step in a gene’s expression of its protein.

Guillermina Lozano and the genetics of...
The MD Anderson scientist and department chair saw something in the DNA of cancer that everyone else overlooked
Cancer180 helps patients, survivors and caregivers between the ages of 18 and 39 connect with other young adults affected by the...
Three male nurses explain why more men are joining the profession
Nicholas Navin wanted to better understand how tumors grow and evolve, so he found a way to analyze the DNA of individual cells
Senior financial analyst Kenny Lee has an amazing story to tell about his journey from Vietnam to America and MD Anderson, where he...
Women with ductal carcinoma in situ face the difficult decision of how to treat the condition. Researchers at MD Anderson are studying...
Their immune system's responders are removed and re-engineered, enabling them to recognize and attack cancer
MD Anderson experts are addressing sleep issues triggered by cancer and cancer treatments that can affect patients’ outcomes and...
Previous Issues
View archives